Orionis Biosciences Patents – Insights & Stats (Updated 2023)

Orionis Biosciences has a total of 232 patents globally, out of which 37 have been granted. Of these 232 patents, more than 86% patents are active. United States of America is where Orionis Biosciences has filed the maximum number of patents, followed by Europe and Canada. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Orionis Biosciences.

Orionis Biosciences was founded in the year 2015. The Company operates in the healthcare industry focusing on the biotechnology business and innovation.

Do read about some of the most popular patents of Orionis Biosciences which have been covered by us in this article and also you can find Orionis Biosciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Orionis Biosciences patent portfolio.

How many patents does Orionis Biosciences have?

Orionis Biosciences has a total of 232 patents globally. These patents belong to 35 unique patent families. Out of 232 patents, 200 patents are active.

How Many Patents did Orionis Biosciences File Every Year?

Orionis Biosciences Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantOrionis Biosciences Applications FiledOrionis Biosciences Patents Granted
20231011
20221715
20211010
202081
201927
2018331
201751
20163

How many Orionis Biosciences patents are Alive/Dead?

Orionis Biosciences Patent Portfolio

How Many Patents did Orionis Biosciences File in Different Countries?

Orionis Biosciences Worldwide Patent Filing

Countries in which Orionis Biosciences Filed Patents

CountryPatents
United States Of America41
Europe35
Canada30
China28
Japan23
Hong Kong (S.A.R.)14
Australia12
Austria4
Korea (South)3
Germany3
Mexico2
Israel2
Singapore2
Norway1
Italy1
Spain1
Denmark1
Brazil1

Where are Research Centres of Orionis Biosciences Patents Located?

R&D Centers of Orionis Biosciences

10 Best Orionis Biosciences Patents

CN110573172A is the most popular patent in the Orionis Biosciences portfolio. It has received 4 citations so far from companies like Therapix Biosciences Ltd., Lava Therapeutics B.V. and Precirix N.V.

Below is the list of 10 most cited patents of Orionis Biosciences:

Publication NumberCitation Count
CN110573172A4
WO2021126973A14
WO2019152979A14
US20210024637A13
CN110546160A3
WO2022011005A13
WO2020198654A13
WO2020097350A13
US11001631B22
US10988538B22

What Percentage of Orionis Biosciences US Patent Applications were Granted?

Orionis Biosciences (Excluding its subsidiaries) has filed 27 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 10 have been granted leading to a grant rate of 100.0%.

Below are the key stats of Orionis Biosciences patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Orionis Biosciences?

Law FirmTotal ApplicationsSuccess Rate
Morgan Lewis & Bockius Llp Bo27100.00%

What are Orionis Biosciences key innovation segments?

What Technologies are Covered by Orionis Biosciences?

The chart below distributes patents filed by Orionis Biosciences in different countries on the basis of the technology protected in patents. It also represents the markets where Orionis Biosciences thinks it’s important to protect particular technology inventions.

R&D Focus: How has Orionis Biosciences search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Orionis Biosciences?

Related Articles

Xiamen Easo Patents – Insights & Stats (Updated 2024)

Xiamen Easo has a total of 681 patents globally, out of which 536 have been granted. Of these 681 patents, more than 59% patents are active. China is where Xiamen Easo has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, China seems

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.